Clinical trial
TheraSphere HUD For Treatment of Unresectable HCC
NCT00683631 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TheraSphere HUD For Treatment of Unresectable HCC
- Lead sponsor
- University of Louisville
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- April 1, 2021
- Enrollment
- 183 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma